Timo’s research article has been cited on “Budget Impact Analysis – Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force” in Value in Health 2014;17:5-14.
ISPOR (International Society for Pharmacoeconomics and Outcomes Research) provides guidances on methods for those undertaking such analyses.
Cited article: Purmonen Timo T, et al. Budget impact analysis of trastuzumab in early breast cancer: a hospital district perspective. Int J Tech Assess Health Care 2010;26:163-169